Synergy CHC Corp. (NASDAQ: SNYR) Stock Competitors & Peer Comparison
See SNYR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SNYR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNYR | $0.09 | +0.00% | 1.3M | -0.06 | -$1.40 | N/A |
| MCK | $994.58 | +1.40% | 116.1B | 24.38 | $40.82 | +0.34% |
| COR | $330.84 | +0.09% | 63.2B | 19.30 | $17.15 | +0.72% |
| CAH | $250.48 | -0.24% | 58B | 24.03 | $10.43 | +0.82% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $84.88 | -1.80% | 9.5B | 15.98 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| AHG | $1.26 | -5.26% | 1.1B | -5.90 | -$0.21 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| EMPG | $17.36 | +0.00% | 143M | 192.89 | $0.09 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
SNYR vs MCK Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, MCK has a market cap of 116.1B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while MCK trades at $994.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas MCK's P/E ratio is 24.38. In terms of profitability, SNYR's ROE is +0.91%, compared to MCK's ROE of -1.94%. Regarding short-term risk, SNYR is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
SNYR vs COR Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, COR has a market cap of 63.2B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while COR trades at $330.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas COR's P/E ratio is 19.30. In terms of profitability, SNYR's ROE is +0.91%, compared to COR's ROE of +1.06%. Regarding short-term risk, SNYR is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
SNYR vs CAH Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, CAH has a market cap of 58B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while CAH trades at $250.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas CAH's P/E ratio is 24.03. In terms of profitability, SNYR's ROE is +0.91%, compared to CAH's ROE of -0.60%. Regarding short-term risk, SNYR is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
SNYR vs ABC Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas ABC's P/E ratio is 21.92. In terms of profitability, SNYR's ROE is +0.91%, compared to ABC's ROE of +1.06%. Regarding short-term risk, SNYR is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
SNYR vs HSIC Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, HSIC has a market cap of 9.5B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while HSIC trades at $84.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas HSIC's P/E ratio is 15.98. In terms of profitability, SNYR's ROE is +0.91%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, SNYR is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
SNYR vs PDCO Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas PDCO's P/E ratio is 20.48. In terms of profitability, SNYR's ROE is +0.91%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, SNYR is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check PDCO's competition here
Akso Health Group (NASDAQ: AHG)
SNYR vs AHG Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, AHG has a market cap of 1.1B. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while AHG trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas AHG's P/E ratio is -5.90. In terms of profitability, SNYR's ROE is +0.91%, compared to AHG's ROE of -0.15%. Regarding short-term risk, SNYR is more volatile compared to AHG. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check AHG's competition here
Owens & Minor, Inc. (NYSE: OMI)
SNYR vs OMI Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas OMI's P/E ratio is -0.47. In terms of profitability, SNYR's ROE is +0.91%, compared to OMI's ROE of +0.63%. Regarding short-term risk, SNYR is more volatile compared to OMI. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check OMI's competition here
Empro Group Inc. Ordinary shares (NASDAQ: EMPG)
SNYR vs EMPG Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, EMPG has a market cap of 143M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while EMPG trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas EMPG's P/E ratio is 192.89. In terms of profitability, SNYR's ROE is +0.91%, compared to EMPG's ROE of +0.66%. Regarding short-term risk, SNYR is more volatile compared to EMPG. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check EMPG's competition here
Akso Health Group (NASDAQ: HX)
SNYR vs HX Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas HX's P/E ratio is -1.84. In terms of profitability, SNYR's ROE is +0.91%, compared to HX's ROE of -1.07%. Regarding short-term risk, SNYR is more volatile compared to HX. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check HX's competition here
111, Inc. (NASDAQ: YI)
SNYR vs YI Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, YI has a market cap of 24.2M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while YI trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas YI's P/E ratio is -1.70. In terms of profitability, SNYR's ROE is +0.91%, compared to YI's ROE of +0.24%. Regarding short-term risk, SNYR is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check YI's competition here
Accendra Health, Inc. (NYSE: ACH)
SNYR vs ACH Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, ACH has a market cap of 19.2M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while ACH trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas ACH's P/E ratio is 0.37. In terms of profitability, SNYR's ROE is +0.91%, compared to ACH's ROE of +0.63%. Regarding short-term risk, SNYR is more volatile compared to ACH. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check ACH's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
SNYR vs MEDS Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, MEDS has a market cap of 8.7M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while MEDS trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas MEDS's P/E ratio is N/A. In terms of profitability, SNYR's ROE is +0.91%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, SNYR is more volatile compared to MEDS. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check MEDS's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
SNYR vs WGRX Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas WGRX's P/E ratio is -0.33. In terms of profitability, SNYR's ROE is +0.91%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, SNYR is more volatile compared to WGRX. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check WGRX's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
SNYR vs HKPD Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, HKPD has a market cap of 4.1M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while HKPD trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas HKPD's P/E ratio is -1.39. In terms of profitability, SNYR's ROE is +0.91%, compared to HKPD's ROE of -0.15%. Regarding short-term risk, SNYR is more volatile compared to HKPD. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check HKPD's competition here
Zynex, Inc. (NASDAQ: ZYXI)
SNYR vs ZYXI Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, SNYR's ROE is +0.91%, compared to ZYXI's ROE of +3.14%. Regarding short-term risk, SNYR is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check ZYXI's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
SNYR vs RDGT Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, RDGT has a market cap of 719.1K. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while RDGT trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas RDGT's P/E ratio is -0.01. In terms of profitability, SNYR's ROE is +0.91%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, SNYR is more volatile compared to RDGT. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
SNYR vs CVET Comparison October 2026
Synergy CHC Corp. (NASDAQ: SNYR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNYR stands at 1.3M. In comparison, CVET has a market cap of 0. Regarding current trading prices, SNYR is priced at $0.09 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNYR currently has a P/E ratio of -0.06, whereas CVET's P/E ratio is -69.97. In terms of profitability, SNYR's ROE is +0.91%, compared to CVET's ROE of -0.06%. Regarding short-term risk, SNYR is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for SNYR.Check CVET's competition here